STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma. [Sen B, et al. Clin Cancer Res 2012;18(1):127-39]
PubMed: 22090359
Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. [Zauli G, et al. Clin Cancer Res 2011;17(4), 762-770]
PubMed: 21106726
Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia. [Lainey E, et al. Oncogene 2012;ahead of print]
PubMed: 23085751
Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion. [Mineo M, et al. Angiogenesis 2012;15(1):33-45]
PubMed: 22203239
Andes virus infection of lymphatic endothelial cells causes giant cell and enhanced permeability responses that are rapamycin and vascular endothelial growth factor C sensitive. [Gavrilovskaya IN, et al. J Virol 2012;86(16):8765-72]
PubMed: 22696643
VEGFR2 and Src kinase inhibitors suppress Andes virus-induced endothelial cell permeability. [Gorbunova EE, et al. J Virol 2011;85(5), 2296-2303]
PubMed: 21177802
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi‐kinase inhibitor Sorafenib with respect to Dasatinib. [Secchiero P, et al. Br J Haematol 2012;157(4):510-4]
PubMed: 22313359
Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells. [Deep G, et al. Cancer Prev Res (Phila). 2011;4(8):1222-32]
PubMed: 21546539
Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action. [Lainey E, et al. Biochem Pharmacol 2011;82(10), 1457-1466]
PubMed: 21664897
Cyclophilin D Extramitochondrial Signaling Controls Cell Cycle Progression and Chemokine-Directed Cell Motility. [Tavecchio M, et al. J Biol Chem 2013;ahead of print]
PubMed: 23303179
Role of increased guanosine triphosphate cyclohydrolase-1 expression and tetrahydrobiopterin levels upon T cell activation. [Chen W, et al. J Biol Chem 2011;286(16):13846-51]
PubMed: 21343293
Effects of the hedgehog inhibitor GDC-0449, alone or in combination with dasatinib, on BCR-ABL-positive leukemia cells. [Okabe S, et al. Stem Cells Dev 2012;21(16):2939-48]
PubMed: 22642671
Molecular characterization of c-Abl/c-Src kinase inhibitors targeted against murine tumour progenitor cells that express stem cell markers. [Kruewel T, et al. PLoS ONE 2010;5(11), e14143]
PubMed: 21152443
The immune inhibitory receptor osteoactivin is upregulated in monocyte-derived dendritic cells by BCR–ABL tyrosine kinase inhibitors. [Schwarzbich MA, et al. Cancer Immunol Immunother 2012;61(2), 193-202]
PubMed: 21874302
Intracellular Retention of ABL Kinase Inhibitors Determines Commitment to Apoptosis in CML Cells. [Lipka DB, et al. PLoS One 2012;7(7):e40853]
PubMed: 22815843
p38α MAP Kinase Dimers with Swapped Activation Segments and a Novel Catalytic Loop Conformation. [Rothweiler U, et al. J Mol Biol 2011;411(2):474-85]
PubMed: 21699901
Dasatinib, a small molecule inhibitor of the Src kinase, reduces the growth and activates apoptosis in pre-neoplastic Barrett's esophagus cell lines: Evidence for a noninvasive treatment of high-grade dysplasia. [Inge LJ, et al. J Thorac Cardiovasc Surg 2013;145(2), 531-538]
PubMed: 23142123
Anti-leukemic activity of Dasatinib in both p53wild-type and p53mutated B malignant cells. [Bosco R, et al. Invest New Drugs 2012;30(1), 417-422]
PubMed: 20953816
Novel, activating KIT-N822I mutation in familial cutaneous mastocytosis. [Wasag B, et al. Exp Hematol 2011;39(8):859-65.e2]
PubMed: 21689725
Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non-Small Cell Lung Cancers. [Cheung HW, et al. Cancer Discov 2011;1(7):608-25]
PubMed: 22586683
Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells in in vitro study. [Uchiyama T, et al. Hematol Oncol 2012;ahead of print]
PubMed: 23108877
Development and Validation of a High-Throughput Intrinsic ATPase Activity Assay for the Discovery of MEKK2 Inhibitors. [Ahmad S, et al. J Biomol Screen 2012;ahead of print]
PubMed: 23134735
High-performance liquid chromatography with ultraviolet detection and protein precipitation as a way of quantitative determination of nilotinib with and without internal … [Marek Dziadosz, et al. Journal of Liquid Chromatography & Related Technologies 2012;35, 17]